Application 201688

Type
NDA
Sponsor
MYLAN SPECIALITY LP

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TOBI PODHALERTOBRAMYCINPOWDER;INHALATION28MGYesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0078-0630TOBI PodhalerTobramycinNovartis Pharmaceuticals CorporationNDACurrent
0078-0630TOBI PodhalerTobramycinNovartis Pharmaceuticals CorporationNDACurrent
0078-0630TOBI PodhalerTobramycinNovartis Pharmaceuticals CorporationNDACurrent
0078-0630TOBI PodhalerTobramycinNovartis Pharmaceuticals CorporationNDACurrent
0078-0630TOBI PodhalerTobramycinNovartis Pharmaceuticals CorporationNDACurrent
0078-0630TOBI PodhalerTobramycinNovartis Pharmaceuticals CorporationNDACurrent
49502-346TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-346TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-346TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-346TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-346TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-346TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-346TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-346TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-346TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-401TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-401TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-401TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent
49502-401TOBI PodhalerTobramycinMylan Specialty L.P.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
73473SUPPL 2023-02-13
73463SUPPL 2023-02-13
63953SUPPL2020-07-17
63895SUPPL2020-07-14
46873SUPPL2017-01-18
46227SUPPL2016-12-20
19031SUPPL2015-10-08
9925SUPPL2015-10-06
40082SUPPL2014-11-20
9924SUPPL2014-11-20
19030SUPPL2014-04-28
9923SUPPL2014-04-28
43370ORIG2014-03-06
24399ORIG2014-03-06
40081ORIG2013-03-26
9922ORIG2013-03-26